Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ronald S. Go
Observed names:
Go RS,
R. Go
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
ORCID:
0000-0002-8284-3495
Observed ORCID:
0000-0002-8284-3495
OpenAlex ID:
A5023266294
Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemia
2025
·
Tamer Hellou
, Shaji K. Kumar
, et al.
·
Blood Cancer Journal
·
5
PDF
Consensus recommendations for malignant histiocytic neoplasms (histiocytic, Langerhans, and interdigitating dendritic cell sarcomas)
2026
·
Gaurav Goyal
, Oussama Abla
, et al.
·
Blood
·
1
Systemic Xanthogranuloma or Erdheim–Chester disease: A systematic review re‐examining the classification challenge
2026
·
Vyshnavi Rallapalle
, Sailesh I. S. Kumar
, et al.
·
British Journal of Haematology
·
1
PDF
Erratum: Design and Staged Implementation of a Multidisciplinary Preoperative Anemia Clinic at a Tertiary Care Medical Center
2026
·
Ethan H. Crispell
, Claire E. Cassianni
, et al.
·
Anesthesia & Analgesia
Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease
2025
·
Tesi M
, Pegoraro F
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
P884: Potential Benefit of Post-transplant Doxycycline in Al Achieving Hematological Response After Autologous Stem Cell Transplant – Long Term Follow up
2022
·
N. Abdallah
, A. Dispenzieri
, et al.
·
HemaSphere
Show more works
View as search
Works count:
6
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type